RNU6-567P

Across TCGA pan-cancer cohorts, RNU6-567P RNA is linked to patient survival in 5 of 34 cancer types, making it the most broadly survival-associated RNU6-567P data layer.

The strongest signal is observed in adrenocortical carcinoma (ACC), where higher RNU6-567P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RNU6-567P expression acts as an unfavorable survival marker.

ACC, LUSC, and KIRC are the cancer types where RNU6-567P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ACC	DFS	Tertile	All	0.010	0.667	<.001	135	view →
LUSC	OS	Tertile	II,III,IV	0.254	0.635	.017	66	view →
KIRC	DFS	Tertile	II,III,IV	0.221	0.760	.017	54	view →
UCEC	DFS	Tertile	All	0.289	0.652	.002	54	view →
BLCA	DFS	Tertile	All	0.015	0.594	<.001	18	view →

Pink = unfavorable, green = favorable. Showing the 5 strongest of 5 lineages.

RNU6-567P–ACC (DFS)

Open the ACC breakdown →